Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Filippo de Marinis"'
Publikováno v:
Expert Review of Anticancer Therapy. 16:799-801
Autor:
Alain Vergnenegre, Dmitry Gultyaev, Javier de Castro Carpeño, Ralph Crott, Martin Kleman, Johanna Lister, Stefan Walzer, Filippo de Marinis, Charles Ngoh, Jie Meng, Christos Chouaid
Publikováno v:
Expert review of anticancer therapy. 15(1)
In recent years, the treatment landscape in advanced non-squamous non-small-cell lung cancer (nsNSCLC) has changed. New therapies (e.g., bevacizumab indicated in first line) have become available and other therapies (e.g., pemetrexed in first line an
Publikováno v:
Expert review of anticancer therapy. 11(10)
After first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC), many patients remain candidates for a second-line treatment. Docetaxel, pemetrexed and erlotinib are currently approved in the USA and Europe as second-line therapy for NS